-transparent.png){kind=logo}
The specificity of human skin collagenase and of an enzyme from an invasive tumor were studied by using types I, II, III, IV, and V (AB) collagen as substrates. Human skin collagenase degraded types I, II, and III collagen, producing the characteristic 3/4 and 1/4 cleavage products, but failed to degrade type IV or V collagen. Collagenase prepared from the invasive tumors showed maximal activity after trypsin treatment. The tumor enzyme degraded type IV (basement membrane) collagen, producing fragments consistent with a single cleavage site but did not attack types I, II, III, and V collagen. Because type IV collagen prepared by pepsinization of placenta was also digested, it is likely that cleavage of type IV collagen by the tumor collagenase occurs within a largely helical domain. A type IV collagenase could play a significant role in tumor metastases and in normal tissues where basement membrane turnover takes place.
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
March 1983,
The Journal of biological chemistry,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
May 1977,
Journal of the National Cancer Institute,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
April 1989,
Methods and findings in experimental and clinical pharmacology,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
August 1990,
Biochimica et biophysica acta,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
January 1977,
The Journal of experimental medicine,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
July 2000,
The Journal of biological chemistry,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
April 1979,
European journal of biochemistry,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
January 1977,
Current problems in clinical biochemistry,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
March 1980,
Nature,
L A Liotta, and
S Abe, and
P G Robey, and
G R Martin
June 1986,
Cancer research,
